Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$78.07
-0.9%
$76.25
$58.93
$95.25
$45.79B1.115.25 million shs3.67 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$512.06
-2.7%
$538.20
$413.82
$616.00
$183.53B1.641.68 million shs2.88 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-0.5%
$23.86
$20.92
$31.54
$145.83B0.5841.80 million shs31.85 million shs
Stryker Corporation stock logo
SYK
Stryker
$389.24
-1.4%
$384.57
$314.93
$406.19
$148.57B0.911.35 million shs801,040 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
+2.05%+2.63%+4.01%+13.66%-15.98%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-0.39%-3.25%-0.67%+6.57%+18.28%
Pfizer Inc. stock logo
PFE
Pfizer
+0.81%+1.27%+6.06%+17.72%-9.11%
Stryker Corporation stock logo
SYK
Stryker
+0.67%+0.68%+2.46%+12.76%+16.99%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
4.4957 of 5 stars
2.23.00.04.03.52.52.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.685 of 5 stars
3.43.00.04.03.02.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9782 of 5 stars
3.23.04.24.53.31.73.1
Stryker Corporation stock logo
SYK
Stryker
4.8116 of 5 stars
3.42.03.34.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.40
Hold$80.403.01% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.70
Moderate Buy$592.5916.02% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.45
Hold$28.5511.37% Upside
Stryker Corporation stock logo
SYK
Stryker
2.79
Moderate Buy$428.5510.08% Upside

Current Analyst Ratings Breakdown

Latest ISRG, EW, SYK, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$73.00 ➝ $77.00
7/8/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$470.00 ➝ $550.00
7/8/2025
Stryker Corporation stock logo
SYK
Stryker
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$390.00 ➝ $415.00
6/9/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell$515.00 ➝ $440.00
6/5/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
6/2/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/29/2025
Pfizer Inc. stock logo
PFE
Pfizer
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold$28.00 ➝ $25.00
5/22/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$84.00 ➝ $95.00
5/22/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$590.00 ➝ $650.00
5/22/2025
Stryker Corporation stock logo
SYK
Stryker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$443.00 ➝ $455.00
5/21/2025
Pfizer Inc. stock logo
PFE
Pfizer
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$32.00 ➝ $33.00
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$5.44B8.42$2.76 per share28.27$17.06 per share4.58
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.92$7.73 per share66.11$46.41 per share11.01
Pfizer Inc. stock logo
PFE
Pfizer
$62.46B2.33$4.37 per share5.86$15.62 per share1.64
Stryker Corporation stock logo
SYK
Stryker
$22.60B6.58$14.98 per share25.99$54.13 per share7.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$4.17B$7.0011.1528.383.8875.48%16.62%12.64%7/23/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.8274.7866.945.6028.41%14.43%12.81%7/22/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3818.588.460.9312.62%20.33%8.53%8/5/2025 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$2.99B$7.4052.6126.252.9612.31%23.74%11.25%7/31/2025 (Estimated)

Latest ISRG, EW, SYK, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/AN/AN/A$13.43 billionN/A
7/31/2025Q2 2025
Stryker Corporation stock logo
SYK
Stryker
$3.06N/AN/AN/A$5.92 billionN/A
7/23/2025Q2 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.62N/AN/AN/A$1.49 billionN/A
7/22/2025Q2 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.92N/AN/AN/A$2.35 billionN/A
5/1/2025Q1 2025
Stryker Corporation stock logo
SYK
Stryker
$2.73$2.84+$0.11$1.69$5.68 billion$5.87 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/23/2025Q1 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.60$0.64+$0.04$0.61$1.40 billion$1.41 billion
4/22/2025Q1 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.71%N/A124.64%16 Years
Stryker Corporation stock logo
SYK
Stryker
$3.360.86%N/A45.41%32 Years

Latest ISRG, EW, SYK, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
5/8/2025
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.840.88%6/30/20256/30/20257/31/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.45
3.66
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.98
3.97
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96
Stryker Corporation stock logo
SYK
Stryker
0.69
1.64
1.00

Institutional Ownership

CompanyInstitutional Ownership
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Stryker Corporation stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
1.29%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.70%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Stryker Corporation stock logo
SYK
Stryker
5.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
15,800586.60 million579.03 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638358.42 million355.91 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Stryker Corporation stock logo
SYK
Stryker
53,000381.69 million359.17 millionOptionable

Recent News About These Companies

Evercore ISI Increases Stryker (NYSE:SYK) Price Target to $415.00
What to Expect From Stryker's Next Quarterly Earnings Report

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$78.07 -0.73 (-0.93%)
Closing price 03:58 PM Eastern
Extended Trading
$78.04 -0.03 (-0.04%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$512.06 -13.99 (-2.66%)
Closing price 04:00 PM Eastern
Extended Trading
$512.38 +0.32 (+0.06%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Pfizer stock logo

Pfizer NYSE:PFE

$25.65 -0.13 (-0.50%)
Closing price 03:59 PM Eastern
Extended Trading
$25.64 0.00 (-0.02%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Stryker stock logo

Stryker NYSE:SYK

$389.24 -5.53 (-1.40%)
Closing price 03:58 PM Eastern
Extended Trading
$389.37 +0.13 (+0.03%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.